Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Evaluation of Anticancer Activity of 4-Vinyl-1-Arylsulfonylimidazolidinones

  • Published : 2006.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

To continue exploration of structure activity relationship of novel 1-(indoline-5-sulfonyl)-4-phenylimidazolidinones (1) reported as anticancer agent with broad spectrum, three 1-(arylsulfonyl)-4-vinylimidazolidinones (2) were synthesized from methyl serinate (3) in 8 steps. Reaction of intermediate 2-phenoxycarbonylaminobut-3-enyl p-toluenesulfonate (10) with arylsulfonamide in the presence of potassium carbonate produced corresponding 2 and N-(4-vinyloxazolidin-2-yl)arylsulfonamide 11 in approximately equal ratio. This reaction is believed to undergo through urea intermediate 16 as shown in scheme 3. 1-Arylsufonyl-4-vinylimidazolidinones 2 show much reduced activity against human colon carcinoma (Colo205), human chronic myelogenous leukemia (K562), and human ovarian adenocarcinoma (SK-OV-3) and compatible activity against human lung carcinoma (A549) compared to 1. Therefore phenyl at 4-position should be the optimum planar motif for the activity of 1.

Keywords

References

  1. Choo Park, H.-Y., Choi, S., Jung, S. H., Koh, H. Y., and Pae, A. N., The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA, Bioorg. Med. Chem., 11, 4585-4589 (2003) https://doi.org/10.1016/S0968-0896(03)00530-3
  2. Ganer, P. and Park, J. M., The synthesis and configurational stability of differentially protected ${\beta}$-hydroxy-${\alpha}$-amino aldehydes, J. Org. Chem., 52, 2361-2364 (1987) https://doi.org/10.1021/jo00388a004
  3. Jung, S.-H., Song, J.-S., Lee, H.-S., Choi, S.-U., and Lee, C.-O., Synthesis and evaluation of cytotoxicity of novel arylsulfonylimidazolidinones containing sulfonylurea pharmacophore. Arch. Pharm. Res., 19, 570-580 (1996) https://doi.org/10.1007/BF02986031
  4. Jung, S.-H., Song, J.-S., Lee, H.-S., Choi, S.-U., and Lee, C.-O., Synthesis and evaluation of cytotoxic activity of novel arylsulfonylimidazolidinones. Bioorg. & Med. Chem. Lett., 6, 2553-2558 (1996) https://doi.org/10.1016/0960-894X(96)00463-5
  5. Jung, S.-H. and Kwak, S.-J., Planar structural requirement at 4- position of 1-arylsulfonyl-4-phenyl-4,5-dihydro-2-imidazolones for their cytotoxicity, Arch. Pharm. Res., 20, 283-287 (1997) https://doi.org/10.1007/BF02976159
  6. Jung, S.-H., Lee, H.-S., Song, J.-S., Kim, H.-M., Han, S.-B., Lee, C.-W., Lee, M., Choi, D.-R., Lee, J.-A., Chung, Y.-H., Yoon, S.-J., Moon, E.-Y., Hwang, H.-S., Seong, S.-K., and Lee, D.-K., Synthesis and antitumor activity of 4-phenyl-1- arylsulfonylimidazolidinones, Bioorg. & Med. Chem. Lett., 8, 2553-2558 (1998)
  7. Jung, S. H., Kwak, S. J., Kim, N. D., Lee, S. U., and Lee, C. O., Stereochemical requirement of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicities, Arch. Pharm. Res., 23, 35- 41 (2000) https://doi.org/10.1007/BF02976463
  8. Jung, S.-H., Park, K.-L., Lee, H.-S., and Whang, J.-S. Evaluation of the role of imidazolidinone motif of Antineoplastic 4- phenyl-1-arylsulfonylimidazolidinones using 4-phenyl-2-arylsulfonyloxazolines, Arch. Pharm. Res., 24, 499-502 (2001) https://doi.org/10.1007/BF02975152
  9. Jung, S.-H., Lee, H.-S., Song, J.-S., Kim, N. -S., Kim, H.-M., Han, S.-B., Lee, C.-W., Lee, M., Choi, D.-R., Lee, J.-A., Chung, Y.-H., Yoon, S.-J., Moon, E.-Y., Hwang, H.-S., Seong, S.-K., and Lee, D.-K., Synthesis and cytotoxic activity of 1(1- benzoylindoline-5-sulfonyl)-4-phenylimidazolidinones, Arch. Pharm. Res., 2004, 478-484
  10. Kim, I.-W., Lee, C.-K., Kim, H.-S., and Jung, S.-H., Importance of sulfonylimidazolidinone motif of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicity: Synthesis of 2-benzoyl- 4-phenyl[1,2,5]thiazolidine-1,1-dioxides and their cytotoxicity, Arch. Pharm. Res., 26, 9-14 (2003) https://doi.org/10.1007/BF03179923
  11. Kim, S., Park, J. H., Koo, S. Y., Kim, J. I., Kim, M. H., Kim, E. J., Jo, K., Choi, H. G., Lee, S. B., and Jung, S. H., Novel diarylsulfonylurea derivatives as potent antimitotic agents, Bioorg. Med. Chem. Lett., 14, 6075-6078 (2004) https://doi.org/10.1016/j.bmcl.2004.09.069
  12. Lee, H.-S., Park, K.-L., Choi, S.-U., Lee, C.-O., and Jung, S.-H., Effect of substituents on Benzenesulfonyl Motif of 4-phenyl- 1-arylsulfonylimidazolidinones for their cytotoxicity, Arch. Pharm. Res., 23, 579-584 (2000) https://doi.org/10.1007/BF02975244
  13. Lee, C. H., Hong, D. H., Han, S. B., Jung, S.-H., Kim, H. C., Fine R. L., Lee, S.-H., and Kim, H. M., A novel stereo-selective sulfonylurea, 1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6- sulfonyl]-4-phenyl-imidazolidin-2-one, has antitumor efficacy in in vitro and in vivo tumor models, Biochemical Pharmacology, 64, 473-480 (2002) https://doi.org/10.1016/S0006-2952(02)01105-X
  14. Moriwake, T., Hamano, S., Saito, S., and Torii, S., A straightforward synthesis of allyl amines from ${\alpha}$-amino acids without racemization, Chem. Lett., 2085-2088 (1987)
  15. Moon, E.-Y., Seong, S.-K., Jung, S.-H., Lee, M., Lee, D.-K. Rhee, D.-K., Pyo, S., and Yoon, S.-J., Antitumor Activity of 4- Phenyl-1-arylsulfonylimidazolidinone, DW2143, Cancer Letters, 140, 177-187 (1999) https://doi.org/10.1016/S0304-3835(99)00070-1
  16. Perrin, D. D., Armarego, W. L. F., and Perrin, D. R., Purification of laboratory chemicals, 2nd edition. Pergamon Press, Oxford, England, (1982)
  17. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monk, A., Tierney, S., Nofziger, T. M., Seniff, D., and Boyd, M. R., Evaluation of a soluble tetrazoliun/formazan assay for cell growth: a sensitivity in culture using human and other tumor cell line, Cancer Res., 48, 4827-4833 (1988)
  18. Williams, L., Zhang, Z., Shao, F., Carroll, P. J., and Joullie, M. M., Grignard reactions to chiral oxazolidine aldehydes, Tetrahedron, 36, 11673-11694 (1996)
  19. Yoon, S. J., Chung, Y. H., Lee, M. S., Choi, D. R., Lee, J. A., Lee, H. S., Yun, H. R., Lee, D. K., Moon, E. Y., Hwang, H. S., Choi, C. H., and Jung, S. H., Arylsulfonylimidazolone Derivatives As An Antitumor Agent, WO 98/07719, PCT/KR 97/00154 (1998)